« Back

Victor J. Cardenas, MD
Professor, Division of Pulmonary Critical Care & Sleep Medicine



Victor J. Cardenas, MD

Victor J. Cardenas, MD
Professor
Pulmonary and Critical Care Medicine
Department of Internal Medicine

University of Texas Medical Branch
301 University Blvd.
Galveston, TX 77555-0561
Phone: 409.772.2436
Fax: 409.772.9532
vcardena@utmb.edu

Education

Degree/Training Completed Year Name & Location
M.D. 1983 University of Texas Medical Branch, Galveston, TX
Residency 1987 University of Texas Medical Branch, Galveston, TX
Chief Residency 1985 University of Texas Medical Branch, Galveston, TX
Fellowship 1990 University of Texas Medical Branch, Galveston, TX

Research Interests

  • Extracorporeal gas exchange in acute respiratory therapy
  • Lung cancer and DNA damage/repair
  • Mechanisms of allergic airway inflammation

Selected Publications

  1. Dharajiya, N., Boldogh, I., Cardenas, V.J., Sur, S.: Role of pollen NAD(P)H oxidase in allergic inflammation. Current Opinion in Allergy and Immunology. 8:57-62, 2008.
  2. Peterson J.R, Graves, D.F., Tacker D.H., Okorodudu, A.O., Mohammad, A.A., Cardenas, V.J., Jr.: Comparison of POCT and central laboratory blood glucose results using arterial, capillary, and venous samples from MICU patients on a tight glycemic protocol. Clin Chim Acta. 396:10-13, 2008.
  3. Cardenas, V.J, Lynch, J.E., Ates, R., Miller, L., Zwischenberger, J.B.: Veno-venous Carbon Dioxide Removal in Chronic Obstructive Pulmonary Disease: Experience in One Patient. ASIAO J. 55(4): 420-422, 2009.
  4. Dharajiya N, Vaidya SV, Murai H, Cardenas V, Kurosky A, et al.: FcγRIIb Inhibits Allergic Lung Inflammation in a Murine Model of Allergic Asthma. (2010) PLoS ONE 5(2): e9337. doi:10.1371/journal.pone.0009337; PMID20179765; PMCID2825267
  5. Shah SK, Cardenas V, Kuo YF, Sharma G.: Rapid Response Team in an Academic Institution – Does it make a Difference? Chest. 2010 Sep 23 (Epub ahead of print)
  6. Dey S, Maiti AK, Hegde ML, Hegde PM, Boldogh I, Sarkar PS, Abdel-Rahman SZ, Sarker AH, Hang B, Xie J, Tomkinson AE, Zhou M, Shen B, Wang G, Wu C, Yu D, Lin D, Cardenas V, Hazra TK; Increased risk of lung cancer associated with a functionally impaired polymorphic variant of the human DNA glycosylase NEIL2. DNA Repair (Amst). 2012 Jun 1;11(6):570-8.
  7. Prys-Picard CO, Shah SK, Williams BD, Cardenas V Jr, Sharma G; Outcomes of Patients on Multiple Vasoactive Drugs for Shock. J Intensive Care Med. 2012 Jun 24.

Clinical Interests

  • Critical Care Medicine
  • Lung Cancer
  • COPD

Patient Care (clinic days, site)

»Pub Med Search
»Curriculum Vitae

The department of internal medicine is developing evidence based clinical protocols which will be available in EPIC (as order sets) for use when admitting patients with these diagnoses. Their AIM is to standardize care and decrease length of stay and readmission rates.

Currently available protocols are:
  • CAP - Community Acquired Pneumonia Orderset
  • Congestive Heart Failure (CHF)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Diabetic Ketoacidosis Adult, ICU
  • General Medicine Admission
  • Immunodeficiency Flow Panel
  • MICU/CCU Admission Order Set
  • Oral Analgesic Medicaitons
  • Parenteral Opioids
  • Sepsis, Adult ICU
  • 111 - Stroke Alert
  • 112 - Stroke Activation
  • 300086 - Stroke Floor Admission
  • 3000000001 -  Stroke Critical care without tPA
  • 300088 Stroke - Transfer from Critical care to floor
  • 3004002 - Stroke Discharge

All protocols can be found in the EPIC order set section.

» For more information

Meaning Use logo

The department of Internal Medicine has a large role in the Meaningful Use Initiative. Our participation is key for the success of the initiative. Please visit the meaningful use website for important communication and updates from the Meaningful Use Initiative.

Site Managed by UTMB Information Design Services.